Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Announces Strategic Review And Engagement Of Financial Advisor

March 12 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS ANNOUNCES STRATEGIC REVIEW AND ENGAGEMENT
OF
FINANCIAL ADVISOR
    * AETERNA ZENTARIS INC - SPECIAL COMMITTEE HAS APPROVED
ENGAGEMENT
BY COMPANY OF TORREYA AS ITS FINANCIAL ADVISOR
    * AETERNA ZENTARIS - TORREYA IS WORKING WITH MANAGEMENT TO
ASSIST
SPECIAL COMMITTEE AND BOARD OF DIRECTORS IN CONSIDERING A WIDE
RANGE OF TRANSACTIONS
    * AETERNA ZENTARIS INC - CONSIDERING POTENTIAL SALE OF
COMPANY
    * AETERNA ZENTARIS - CONSIDERING OPPORTUNITIES FOR LICENSE
OF
MACIMORELIN OUTSIDE OF U.S. AND CANADA, OTHER MONETIZATION DEALS
RELATING TO MACIMORELIN

Source text for Eikon:  ID:nGNX9sSm5H 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on COSCIENS Biopharma

See all news